ARTICLE | Clinical News
SRN-001: Phase I started
June 21, 2004 7:00 AM UTC
Sirenade started a single-dose, cross-over Phase I trial in healthy volunteers. The study is comparing the pharmacokinetics of 2 sustained-release formulations of SRN-001 with an immediate-release for...